Description

• Seed & Early Stage: Focuses on companies ranging from Idea-stage and Pre-Seed through Series A.
• De-Risked Growth: They prioritize technology-enabled products and services that have been vetted by affiliated accelerators, incubators, or syndicates to reduce risk and speed time to market. 
• Submission Method: Entrepreneurs typically engage via investor portals or through warm introductions from partner accelerators and incubators.
• Thematic Focus: For 2026, the firm prioritizes innovations that significantly impact cost, access, and quality of care, particularly in digital health, clinical redesign, and data analytics.

Eligibility

• Sector focus: Technology-enabled products, medical products, data analytics, and digital health in both acute and post-acute settings.
• Business Model: Must be for-profit companies with scalable solutions likely to succeed over a five-year horizon.
• Geography: While headquartered in the San Francisco Bay Area, they source and support innovative healthcare companies globally. 

Process

1. Curation & Screening: The team reviews opportunities sourced through their strategic network and investor portals.
2. Team-Based Advisory: Advisors work as a cohesive unit to evaluate clinical and technical feasibility using their "ringside seat" experience in health systems.
3. Active Partnership: Beyond capital, they provide mentorship and direct connections to strategic partners, including payers and providers.

What an Applicant can Obtain

• Expert Mentorship: Direct guidance from senior business leaders, former founders, and physicians.
• Strategic Access: Introductions to a network of corporate venture groups, health systems, and private equity firms.
• Operational Support: Advisory in areas such as IT integration, clinical redesign, and regulatory compliance.